{"data":{"id":"us-mn/minn.-stat.-62j.93","jurisdiction":"us-mn","citation":"Minn. Stat. § 62J.93","heading":"REPORTS.","body":"Beginning March 1, 2024, and each March 1 thereafter, the board shall submit a report to the governor and legislature on general price trends for prescription drug products and the number of prescription drug products that were subject to the board's cost review and analysis, including the result of any analysis as well as the number and disposition of appeals and judicial reviews.","path":["INSURANCE","CHAPTER 62J. HEALTH CARE COST CONTAINMENT","PRICE TRANSPARENCY; INFORMATION REPORTING"],"source_url":"https://www.revisor.mn.gov/statutes/cite/62J.93","current_through":"2025 Minnesota Statutes","vintage":"","retrieved_at":"2026-09-02T22:10:28Z","sha256":"4aa6b55893074b049a73684b1e8d6c0e0cf3ba71311b1c857e3c90ffc24e7574","source_id":"us-mn","stale":false,"prev":"us-mn/minn.-stat.-62j.92","next":"us-mn/minn.-stat.-62j.94"},"notice":"GroundRules: Original legal text. Not legal advice."}